You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NEI-VFQ-25

Showing 1 - 25 of 6,974
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Quality of Life and Social Support in Age-Related Macular

Recruiting
  • Age-Related Macular Degeneration
  • National Eye Institute Visual Function Questionnaire
  • Almaty, Kazakhstan
  • +1 more
Aug 16, 2022

Personality, Patient Satisfaction, Presbyopia Trial in Alexandroupolis (TPQue Greek version, NEI-VFQ-25 Greek version)

Active, not recruiting
  • Personality
  • +2 more
  • TPQue Greek version, NEI-VFQ-25 Greek version
  • Alexandroupolis, Evros, Greece
    Department of Ophthalmology, University Hospital of Alexandroupo
Dec 30, 2021

Pigmentary Retinopathy Trial in Paris (Locomotion task, Posturology task SOT (Sensory Organization Test), The quality of life

Recruiting
  • Pigmentary Retinopathy
  • Locomotion task
  • +2 more
  • Paris, France
    Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Jun 3, 2020

Croatian Version of Ocular Surface Disease Index Questionnaire

Active, not recruiting
  • Dry Eye
  • Ocular Surface Disease
  • Questionnaires and dry eye tests
  • Zagreb, Croatia
    University Hospital Sestre milosrdnice
Jul 9, 2023

Multiple Sclerosis, Internuclear Ophthalmoplegia Trial in Amsterdam (Clemastine Fumarate, Placebo)

Recruiting
  • Multiple Sclerosis
  • Internuclear Ophthalmoplegia
  • Clemastine Fumarate
  • Placebo
  • Amsterdam, Netherlands
    Amsterdam UMC, location VUmc
Sep 21, 2022

'Distortion as a Predictor of ERM Surgery Outcome'

Not yet recruiting
  • Epiretinal Membrane
  • +2 more
  • Epiretinal membrane surgery
  • Paisley, United Kingdom
    NHS Greater Glasgow and Clyde Clinical Research and Development
Mar 9, 2021

Glaucoma, Age-related Macular Degeneration, Retinitis Pigmentosa Trial in Guangzhou (New head-mounted visual aids)

Not yet recruiting
  • Glaucoma
  • +3 more
  • New head-mounted visual aids
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Oct 7, 2023

X-linked Retinoschisis Trial (ATSN-201)

Not yet recruiting
  • X-linked Retinoschisis
  • ATSN-201
  • (no location specified)
May 26, 2023

Non-infectious Uveitis Trial (care strategy)

Not yet recruiting
  • Non-infectious Uveitis
  • care strategy
  • (no location specified)
Jun 26, 2023

Idiopathic Intracranial Hypotension, Venous Sinus Stenosis Trial in Beijing (procedure, drug, behavioral)

Active, not recruiting
  • Idiopathic Intracranial Hypotension
  • Venous Sinus Stenosis
  • Stent Implantation
  • +2 more
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Jan 28, 2023

Evaluate Functional and Anatomical Progression in Retinitis

Recruiting
  • Retinitis Pigmentosa
    • Baltimore, Maryland
      Wilmer Eye Institute at Johns Hopkins University
    Sep 15, 2022

    Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in Tehran (Aflibercept (CinnaGen Co, Iran),

    Completed
    • Age-Related Macular Degeneration
    • Neovascular Age-related Macular Degeneration
    • Aflibercept (CinnaGen Co, Iran)
    • Aflibercept (Regeneron, USA)
    • Tehran, Iran, Islamic Republic of
      Farabi Hospital
    Oct 16, 2022

    Cataract, Intraocular Lens Implant Trial (Zeiss CT Asphina / Zeiss CT Asphina, Zeiss AT Lara/ Zeiss AT Lisa Tri, Zeiss CT

    Not yet recruiting
    • Cataract
    • Intraocular Lens Implant
    • Zeiss CT Asphina / Zeiss CT Asphina
    • +3 more
    • (no location specified)
    Jan 23, 2023

    Myopia Trial in Shenyang (0.01% atropine, 0.9% sodium chloride)

    Not yet recruiting
    • Myopia
    • 0.01% atropine
    • 0.9% sodium chloride
    • Shenyang, Liaoning, China
      He Eye Hospital
    Sep 10, 2023

    NorMIGS - a Study of Micro-invasive Glaucoma Surgery

    Recruiting
    • Glaucoma
    • Preserflo microshunt
    • +2 more
    • Oslo, Norway
      Department of Ophthalmology, Oslo University Hospital
    Nov 26, 2022

    Retinitis Pigmentosa Trial (ZVS203e)

    Not yet recruiting
    • Retinitis Pigmentosa
    • (no location specified)
    Mar 27, 2023

    Primary Open-angle Glaucoma Trial in Maastricht (PRESERFLO Microshunt implantation, Trabeculectomy)

    Recruiting
    • Primary Open-angle Glaucoma
    • PRESERFLO Microshunt implantation
    • Trabeculectomy
    • Maastricht, Limburg, Netherlands
      Maastricht University Medical Center+ (MUMC+)
    Aug 16, 2022

    Retinal and Cognitive Dysfunction in Type 2 Diabetes

    Active, not recruiting
    • Retinal Function
    • +2 more
      • Barcelona, Spain
        Rafael Simó
      Aug 30, 2022

      Persistent Corneal Epithelial Defect Trial in United States (lufepirsen, Vehicle)

      Recruiting
      • Persistent Corneal Epithelial Defect
      • Pasadena, California
      • +5 more
      Jul 21, 2023

      Weiss Ring Trial in Dongyang (YAG vitreolysis)

      Recruiting
      • Weiss Ring
      • YAG vitreolysis
      • Dongyang, Zhejiang, China
        Dongyang People's Hospital
      Apr 4, 2023

      Quality of Life Assessment in Cancer Patients and Survivors With

      Recruiting
      • Cancer
      • Dermatologic Conditions
      • Quality of Life (QoL) Assessment
      • Basking Ridge, New Jersey
      • +3 more
      Jan 18, 2023

      Bietti's Crystalline Dystrophy Trial in China (ZVS101e)

      Recruiting
      • Bietti's Crystalline Dystrophy
      • Beijing, Beijing, China
      • +3 more
      Apr 16, 2023

      Bietti Crystalline Dystrophy Trial in Shanghai (VGR-R01)

      Not yet recruiting
      • Bietti Crystalline Dystrophy
      • VGR-R01
      • Shanghai, Shanghai, China
        Shanghai Vitalgen Biopharma Co.,Ltd.
      Jan 20, 2023

      Geographic Atrophy, Macular Degeneration Trial in United States (JNJ-81201887, Prednisone, Placebo)

      Recruiting
      • Geographic Atrophy
      • Macular Degeneration
      • Phoenix, Arizona
      • +3 more
      Mar 31, 2023

      Primary Open Angle Glaucoma Trial in Philadelphia (GlaucoCetin, Placebo)

      Recruiting
      • Primary Open Angle Glaucoma
      • GlaucoCetin
      • Placebo
      • Philadelphia, Pennsylvania
        Wills Eye Hospital, Glaucoma Research Center
      Jun 30, 2022